Global Scar Treatment Market(1)
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Global</strong> <strong>Scar</strong> <strong>Treatment</strong> <strong>Market</strong> is projected to expand at a healthy CAGR of 3.9 % by 2025<br />
Persistence <strong>Market</strong> Research (PMR) delivers key insights and presents a revised forecast of the<br />
global scar treatment market for an eight year period from 2017 to 2025 in the report titled “<strong>Scar</strong><br />
<strong>Treatment</strong> <strong>Market</strong>: <strong>Global</strong> Industry Analysis 2012–2016 and Forecast 2017–2025.” The revision in<br />
the market size and forecasts have been carried out taking into account the impact of various<br />
macroeconomic indicators and other industry-based demand-driving factors, as well as the recent<br />
developments of key market participants. The global scar treatment market is projected to expand at<br />
a healthy CAGR of 3.9 % in terms of value during the forecast period, revised from the previous<br />
CAGR of 3.8%, due to factors regarding which PMR offers useful insights in detail in this report.<br />
Report overview @ https://www.persistencemarketresearch.com/market-research/global-scartreatment-market-102017.asp<br />
Key <strong>Market</strong> Dynamics<br />
The prime drivers for the market include availability of attractive reimbursement facilities in<br />
developed markets and rising incidences of atrophic scars (primarily acne) in developing markets,<br />
primarily due to rapidly changing food habits and lifestyles. Furthermore, growing adoption of<br />
combination therapeutics is another factor expected to drive demand for various combinations of<br />
scar treatment product and treatments over the forecast period. Currently, there are no formalized<br />
guidelines for treatment of scars. All treatments are done on a best-effort basis, guided mostly<br />
through word-of-mouth by expert clinicians and surgeons. However, efforts are underway to<br />
formalize treatment guidelines at least for common scars. In this regard, under the U.K.<br />
government’s cosmetic intervention guidelines, patient and patient parties need access to<br />
independent and evidence-based information to form their decisions. Many of these scar treatment<br />
and aesthetic beautification procedures are considered similar to ‘consumer goods’ by both the<br />
purchaser and provider. A change in this perspective could help boost manufacturers and service<br />
provider’s potential revenue base.<br />
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/19357<br />
Barriers to the market include fragmented documented clinical evidences for popular topical<br />
products such as onion extract gels (containing silicone). This hampers the product uptake by the<br />
educated section of the patient base in both developed and developing countries. Other barriers<br />
include psychological issues such as fear of side-effects and consideration of scar treatment as a<br />
non-necessary expenditure item in the overall consumption basket. Even some of the well-known<br />
regulatory agencies do not accept scar treatments as medically necessary as they mostly are not lifechanging<br />
in nature.<br />
<strong>Market</strong> Segmentation & Forecast<br />
In the report, the global scar treatment market is analyzed based on product-type, scar type, enduser<br />
(distribution channel), and region. Based on product type, the overall market has been<br />
segmented into topical products, laser products, surface treatment products, and injectable products.<br />
The topical product segment is further segmented into creams, gels, oils, and silicone gel sheets.<br />
The laser segment has been sub-segmented into CO2, excimer, and pulse-dyed lasers. Based on scar<br />
type, the market has been sub-segmented into atrophic scars, hypertrophic scars and keloids,<br />
contractures, and stretch marks. The distribution channels or end-users in the market include<br />
hospitals, private clinics, pharmacies and retail drug stores, and e-commerce. The market has been<br />
analyzed in terms of value. In the overall market, topical products and atrophic scars are the prime<br />
segments driving revenue growth currently. Accordingly, the topical product type segment is
expected to reach a value of US$ 473.8 Mn by the end of 2025, registering a moderate CAGR over<br />
the forecast period.<br />
Regional Forecast<br />
Based on region, the market has been divided into North America, Latin America, Europe, Asia<br />
Pacific, and the MEA. Developed pharmaceutical markets such as the U.S. and EU are expected to<br />
emerge as the main markets for scar treatment products over the forecast period, while markets in<br />
Brazil and Central Asia are expected to witness growing adoption of laser treatments due to<br />
booming medical tourism and aesthetic corrective procedures in these regions. Increasing<br />
involvement of patients in treatment formulation processes is an important attribute being adopted<br />
by reputed physicians as it could lead to a marked improvement in adherence levels of prescribed<br />
treatments and increase treatment effectiveness. This report assesses the market trends, by product,<br />
scar type, end user and region, to offer analytical insights about the potential emerging demand for<br />
particular scar treatments in specific regions. North America is estimated to dominate the scar<br />
treatment market over the forecast period, accounting for maximum revenue share of the overall<br />
market by the end of 2015. <strong>Market</strong>s in Latin America and APAC region are estimated to expand at<br />
the most significant CAGR over the forecast period.<br />
Get Full Report now @ https://www.persistencemarketresearch.com/checkout/19357<br />
Vendor Landscape<br />
Key companies covered in this report include Smith & Nephew PLC, Merz Inc., Enaltus LLC,<br />
Occulus Innovative Sciences Inc., CCA Industries Inc., Cynosure Inc, Avita Medical Limited,<br />
Lumenis, Syneron Medical Ltd., Nutramarks Inc., Mölnlycke Health Care, Pacific World<br />
Corporation, Valeant Pharmaceuticals International Inc. and Shanghai Fosun Pharmaceuticals Ltd.<br />
(AC. Alma Lasers). These companies are primarily focused on enhancing their product portfolio<br />
through research and development and on the introduction of innovative and cost-effective<br />
advanced manufacturing procedures in order to gain higher market share and to strengthen their<br />
respective positions in the global market.<br />
About Us<br />
Persistence <strong>Market</strong> Research (PMR) is a third-platform research firm. Our research model is a<br />
unique collaboration of data analytics and market research methodology to help businesses achieve<br />
optimal performance.To support companies in overcoming complex business challenges, we follow<br />
a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional<br />
sources. By deploying real-time data collection, big data, and customer experience analytics, we<br />
deliver business intelligence for organizations of all sizes.<br />
Contact Us<br />
Persistence <strong>Market</strong> Research<br />
305 Broadway<br />
7th Floor, New York City,<br />
NY 10007, United States,<br />
USA – Canada Toll Free: 800-961-0353<br />
Email: sales@persistencemarketresearch.com<br />
Web: http://www.persistencemarketresearch.com
Change language